KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) EBT Margin (2016 - 2025)

Historic EBT Margin for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to 17.82%.

  • Medtronic's EBT Margin fell 7300.0% to 17.82% in Q4 2025 from the same period last year, while for Oct 2025 it was 16.4%, marking a year-over-year increase of 7800.0%. This contributed to the annual value of 16.78% for FY2025, which is 18400.0% up from last year.
  • As of Q4 2025, Medtronic's EBT Margin stood at 17.82%, which was down 7300.0% from 15.18% recorded in Q3 2025.
  • Medtronic's 5-year EBT Margin high stood at 20.47% for Q1 2022, and its period low was 9.95% during Q2 2024.
  • For the 5-year period, Medtronic's EBT Margin averaged around 16.67%, with its median value being 17.81% (2025).
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 157100bps in 2021, then plummeted by -82000bps in 2024.
  • Medtronic's EBT Margin (Quarter) stood at 19.03% in 2021, then decreased by -3bps to 18.39% in 2022, then fell by -11bps to 16.45% in 2023, then grew by 13bps to 18.55% in 2024, then fell by -4bps to 17.82% in 2025.
  • Its EBT Margin was 17.82% in Q4 2025, compared to 15.18% in Q3 2025 and 14.13% in Q2 2025.